Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Exploring the Potential of Madrigal Pharmaceuticals' Resmetirom in Treating NASH: Insights from the Phase 3 MAESTRO-NASH Trial

Ticker(s): MDGL

Who's the expert?

Institution: The Iowa Clinic

Senior GI with 20 years of experience
I am a gastroenterologist in Des Moines Iowa with 21 years of experience.
I have about 300 patients with NERD
Yes I am familiar with Phase 2 Trial of Vonoprazan

Interview Goal

Discussing the standard of care and the potential of Madrigal Pharma's Resmetirom for treating NASH and the new data from the Phase 3 MAESTRO-NASH trial.

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.